Oncology & Cancer

New treatment approved for common skin cancer

(HealthDay)—Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat advanced squamous cell carcinoma (CSCC), the agency said in a news release.

Oncology & Cancer

Review: Treatments for primary basal cell carcinoma compared

(HealthDay)—For patients with primary basal cell carcinoma (BCC), estimated recurrence rates are similarly low for excision, Mohs surgery, curettage and diathermy, and external-beam radiation, according to a review and ...

page 37 from 40